Related Experiment Video
Updated: Jul 13, 2026

Synthesis of Strong Adhesive Hydrogel, Gelatin O-Nitrosobenzaldehyde
Published on: November 11, 2022
Antifungal hydrogels
Andreas Zumbuehl1, Lino Ferreira, Duncan Kuhn
1Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, and University Hospitals of Cleveland, OH, USA.
Abstract:
Fungi are increasingly identified as major pathogens in bloodstream infections, often involving indwelling devices. Materials with antifungal properties may provide an important deterrent to these infections. Here we describe amphogel, a dextran-based hydrogel into which amphotericin B is adsorbed. Amphogel kills fungi within 2 h of contact and can be reused for at least 53 days without losing its effectiveness against Candida albicans. The antifungal material is biocompatible in vivo and does not cause hemolysis in human blood. Amphogel inoculated with C. albicans and implanted in mice prevents fungal infection. Amphogel also mitigates fungal biofilm formation. An antifungal matrix with these properties could be used to coat a variety of medical devices such as catheters as well as industrial surfaces.
Insights
A new dextran-based hydrogel, amphogel, effectively kills fungi on contact and prevents infections. This reusable, biocompatible material shows promise for medical devices and industrial surfaces.
Area of Science:
- Mycology
- Biomaterials Science
- Infectious Diseases
Background:
- Fungal bloodstream infections are a growing concern, particularly with indwelling medical devices.
- Antifungal materials are needed to prevent device-associated fungal infections.
- Candida albicans is a common cause of fungal infections.
Purpose of the Study:
- To develop and evaluate a novel antifungal hydrogel, amphogel, for preventing fungal infections.
- To assess the efficacy, reusability, and biocompatibility of amphogel.
- To investigate amphogel's potential in preventing fungal biofilm formation and in vivo infections.
Main Methods:
- Amphogel was created by adsorbing amphotericin B onto a dextran-based hydrogel.
- Antifungal activity was tested against Candida albicans, assessing contact time and reusability.
- Biocompatibility was evaluated through in vivo implantation in mice and in vitro hemolysis assays.
- Fungal infection prevention and biofilm mitigation were assessed in mouse models.
Main Results:
- Amphogel demonstrated rapid antifungal activity, killing fungi within 2 hours of contact.
- The material maintained effectiveness against Candida albicans after at least 53 reuse cycles.
- Amphogel proved biocompatible in vivo and did not cause hemolysis in human blood.
- Implantation of amphogel in mice prevented fungal infection and mitigated biofilm formation.
Conclusions:
- Amphogel is a highly effective, reusable, and biocompatible antifungal hydrogel.
- This material offers a promising strategy for preventing fungal infections associated with medical devices.
- Amphogel has potential applications in coating medical devices and industrial surfaces to combat fungal contamination.
Related Concept Videos
Antifungal Agents
Candidiasis